AMR vs Chad: Hepatitis B surface antigen (HBsAg) prevalence (%)
AMR
0.0%
in 2024
Chad
2.2%
in 2024
AMR rank
12th
Chad rank
11th
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- AMR
- Chad
How they compare
Chad currently reports 2.2% against 0.0% in AMR, a difference of 2.2%.
Across all 10 years both countries report, Chad has been ahead every year.
AMR ranks 12th and Chad ranks 11th of 13 groups.
Chad has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | AMR | Chad | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 4.1% | 4.1% | Chad |
| 2020s | 0.0% | 3.0% | 3.0% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, AMR or Chad?
- Chad, at 2.2% against 0.0% in AMR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between AMR and Chad?
- 2.2%, with Chad ahead.
- How many years of comparable data are there for AMR and Chad?
- 10 years are reported by both, from 2015 to 2024.
- How do AMR and Chad rank globally for hepatitis b surface antigen (hbsag) prevalence?
- AMR ranks 12th and Chad ranks 11th of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.